If you are considering genicular artery embolization (GAE) for knee osteoarthritis, imaging plays a central role at every stage of the process. It helps determine whether you are a candidate, guides the procedure itself in real time, and tracks your response afterward. Understanding what each type of imaging tells your physician, and why each one matters, helps you navigate the process with confidence and ask the right questions at your consultation.
This article walks through the three main imaging studies involved in GAE: standing knee X-rays for diagnosis and grading, MRI for detailed soft-tissue assessment, and the real-time angiogram that guides the procedure from start to finish.
Who Is a Candidate for GAE?
Before discussing imaging in detail, it helps to understand the clinical picture that GAE is designed to address.
GAE may be an option if you have knee osteoarthritis pain that has not improved with at least three months of conservative care, such as medication, physical therapy, or injections, and you are not ready for, or are not a candidate for, knee replacement. It tends to work best for mild to moderate arthritis, though some people with more advanced arthritis may also benefit.
Imaging is how your physician objectively evaluates where your arthritis stands on the severity spectrum, identifies the inflammatory features that GAE targets, and confirms that your symptoms are likely to respond to the procedure.
Standing Knee X-Rays: The Foundation
Standing knee X-rays are the first and most important imaging study in GAE evaluation. They establish the diagnosis of osteoarthritis, measure the degree of cartilage loss and joint space narrowing, and assign a Kellgren-Lawrence (KL) grade, the standardized classification system used in every published GAE clinical trial.
Why standing (weight-bearing) films are essential. When you stand, the weight of your body compresses the knee joint, bringing the bone surfaces closer together and revealing the true extent of cartilage loss between them. A non-weight-bearing X-ray, taken while you are lying down or sitting, removes this compression and can significantly underestimate joint space narrowing. A knee that looks mildly arthritic on a non-weight-bearing film may look considerably worse on a standing image. For accurate grading, always request standing anteroposterior (AP) and lateral views.
What your physician looks for on the X-ray. The key features include joint space narrowing (indicating cartilage loss), osteophytes (bone spurs at the joint margins), subchondral sclerosis (increased bone density beneath the cartilage surface), and bony deformity or malalignment. The pattern and severity of these findings determine the KL grade.
Understanding Kellgren-Lawrence Grading
The Kellgren-Lawrence (KL) grading system, originally described in 1957 and still the worldwide standard, classifies knee osteoarthritis severity into five grades based on X-ray appearance. Understanding where your knee falls on this scale is essential because it directly informs whether GAE is likely to be effective for you.
Grade 0: Normal. No radiographic features of osteoarthritis. The joint space is preserved, and there are no osteophytes, sclerosis, or bony changes. A grade 0 knee has no imaging evidence of arthritis.
Grade 1: Doubtful. There may be a tiny, questionable osteophyte at the joint margin, but joint space is fully preserved. These changes are subtle enough that different radiologists might disagree about whether they represent early arthritis or normal variation. Most patients with grade 1 findings do not have enough inflammatory neovascularity (abnormal new blood vessel growth) for GAE to target effectively.
Grade 2: Mild. Definite osteophytes are present, and there may be possible (slight) narrowing of the joint space. This is the stage at which osteoarthritis becomes clearly visible on X-ray. Cartilage is thinning but still provides meaningful cushioning. Grade 2 represents a common starting point for GAE candidacy.
Grade 3: Moderate. Multiple osteophytes are present, the joint space is definitively narrowed, and there is subchondral sclerosis (denser, whiter bone beneath the cartilage). Some early bony deformity may be developing. This grade represents the clinical “sweet spot” for GAE in many published studies: there is significant disease driving inflammation and pain, but enough cartilage and joint architecture remain that reducing the inflammatory component can provide meaningful relief.
Grade 4: Severe. Large osteophytes, marked joint space narrowing (approaching or reaching bone-on-bone contact), severe sclerosis, and definite bony deformity or malalignment. At this stage, the cartilage is largely gone, and the structural damage to the joint is advanced. Knee replacement is typically the most effective treatment for grade 4 disease. However, some patients with grade 4 findings who are not candidates for surgery, or who wish to delay it, may still benefit from GAE. The decision is individualized and discussed at the consultation.
How grading guides the GAE decision. GAE tends to work best for KL grades 2 and 3, where there is enough inflammatory neovascularity to target with microspheres but enough remaining joint structure to allow meaningful functional improvement once the inflammatory component is reduced. Published trial data, including the 2025 prospective study of 25 patients that demonstrated a 55 percent reduction in pain scores at one year, have drawn primarily from this population. Durability data show that approximately 5 percent of GAE patients required knee replacement within two years, and approximately 8 percent had a repeat GAE procedure.
What MRI Adds to the Picture
While standing X-rays are essential for grading, MRI provides a different and complementary layer of information. MRI excels at visualizing soft tissues and internal joint structures that X-rays cannot show.
Synovitis (joint lining inflammation). The synovial membrane is the thin tissue lining the inside of the knee joint. In osteoarthritis, this membrane can become inflamed, thickened, and hypervascular (developing an abnormal network of new blood vessels). This synovitis is a major driver of pain and the specific target of GAE. MRI with contrast enhancement can detect and quantify synovitis, and research suggests that patients with prominent synovitis on MRI may be more likely to respond well to GAE. In other words, MRI can help identify the patients whose pain has a significant inflammatory component, exactly the pathology that GAE addresses.
Bone marrow edema. Also called bone marrow lesions, these areas of fluid signal within the bone adjacent to the joint surface indicate stress and microdamage in the subchondral bone. Bone marrow edema is associated with pain and with risk of disease progression. Its presence on MRI suggests active, symptomatic disease rather than quiet, chronic degeneration.
Meniscal tears and other structural pathology. The menisci are C-shaped cartilage cushions inside the knee that can tear with age and arthritis. MRI can detect meniscal tears, ligament damage, loose bodies (fragments of cartilage or bone floating in the joint), and Baker’s cysts (fluid-filled cysts behind the knee). Identifying these additional pain generators is important because it helps your physician determine whether your pain is primarily from osteoarthritis-related inflammation (which GAE targets) or from a structural problem (such as a large, symptomatic meniscal tear) that might require a different approach.
Is MRI always required before GAE? Not universally. Standing X-rays are the essential baseline. MRI is recommended when additional information would help refine candidacy, when X-ray grading is borderline, when there is suspicion of another diagnosis contributing to pain, or when your physician wants to assess the inflammatory component before proceeding. At your consultation, Dr. Chun will determine whether MRI is needed based on your X-rays, symptoms, and clinical examination.
During the Procedure: Real-Time Angiographic Guidance
The third type of imaging involved in GAE is the angiogram, and it happens during the procedure itself. This is the real-time X-ray mapping that guides the treatment from start to finish.
How the angiogram works. GAE is performed entirely under fluoroscopic guidance (live X-ray imaging). The procedure begins with a small puncture in the groin to access the femoral artery. Through this puncture site, a thin catheter is advanced through the arterial system and into the genicular arteries, the small branches that supply blood to the tissues around the knee joint. Once the microcatheter is positioned, contrast dye is injected.
The contrast flows through the genicular arteries and into the surrounding tissue, creating a detailed, real-time map of the knee’s blood supply on the fluoroscopy monitor. In a healthy knee, the arteries branch normally and the contrast clears quickly. In an arthritic knee with active inflammation, the angiogram reveals something distinctive: areas of abnormal neovascularity, a dense, tangled network of tiny new blood vessels that has grown into the inflamed synovial tissue. On the screen, this appears as a characteristic pattern called the “synovial blush,” a cloud-like area of contrast enhancement where the inflammatory vessels are concentrated.
Targeted treatment. The physician uses this live angiographic map to selectively deliver microscopic particles (microspheres) to the abnormal vessels causing the inflammatory blush. The microspheres block blood flow to the pathological neovascularity while preserving normal arterial supply to the surrounding healthy tissue. This precision is the defining advantage of GAE: treatment is delivered specifically to the diseased vasculature, guided by live imaging, not applied broadly to the entire joint.
Procedure details. GAE takes 60 to 90 minutes, performed under IV sedation and local anesthesia. The groin puncture site is closed with a bandage (no stitches). Patients typically spend three to four hours at the facility and go home the same day. Most patients can return to desk work within two to three days and begin gentle exercise within the first week, with one to three days of downtime. Pain improvement typically begins within two to four weeks and continues to build over three months.
After the Procedure: Follow-Up Imaging
Following GAE, routine imaging is not standard practice. The primary measure of success is clinical response: how much your pain has improved, how much your function has recovered, and how your quality of life has changed.
However, follow-up imaging can be valuable in certain situations. If clinical improvement is incomplete, or if there is a question about whether the arthritis has progressed, follow-up X-rays can assess whether joint space has been maintained. An MRI can evaluate whether synovitis has been reduced, which would confirm that the procedure addressed its target. In cases where a repeat GAE is being considered (approximately 8 percent of patients in published data), pre-procedure imaging is obtained to reassess the anatomy and guide retreatment.
At Surgical Associates, follow-up visits are scheduled to track pain and function after GAE. Your physician will recommend additional imaging if and when it would change management.
What to Bring to Your Consultation
To make the most of your consultation, bring any recent knee imaging (X-rays or MRI) on disc, through a patient portal, or request that the imaging facility send the studies electronically. If you have had imaging at multiple facilities, bring all of it. Comparing older and newer studies helps your physician assess how your arthritis has changed over time.
If you do not have recent imaging, it can be ordered at your consultation. Standing (weight-bearing) knee X-rays are the minimum requirement. Your physician will determine whether MRI is also needed based on your clinical evaluation.
What to ask your doctor: “Based on my imaging, what is my Kellgren-Lawrence grade? Is there evidence of active inflammation that GAE could target? Do I need an MRI, or are my X-rays sufficient to make a decision?”
Insurance and Next Steps
Coverage varies by plan; our team checks your benefits. Some insurance plans require a referral; our insurance team can help sort this out.
If you have knee osteoarthritis pain that has not responded to conservative treatments and you want to understand whether GAE could help, the first step is a consultation with imaging review. Dr. Albert Chun reviews all imaging at the visit and explains exactly where your arthritis stands, what the imaging shows about your inflammatory activity, and whether GAE is a reasonable option for your situation.
Schedule a GAE consultation: Call (240) 427-1630 or visit sacmd.com/contact
Frequently Asked Questions
Do I need an MRI before GAE?
Not always, but MRI can provide valuable information. Standing knee X-rays are the essential baseline imaging because they establish the Kellgren-Lawrence grade and confirm the diagnosis. MRI adds detail about synovitis (joint lining inflammation), bone marrow edema, and meniscal pathology. This information can help predict which patients are most likely to respond to GAE and rule out other sources of knee pain. Your physician will determine whether MRI is needed based on your X-rays, symptoms, and clinical examination.
What is Kellgren-Lawrence grading?
The Kellgren-Lawrence (KL) system is the standard classification used worldwide to grade knee osteoarthritis severity on X-ray. It ranges from grade 0 (no radiographic disease) through grade 4 (severe, with marked joint space loss and bone-on-bone contact). Grade 2 represents mild OA with definite osteophytes and possible joint space narrowing. Grade 3 represents moderate OA with multiple osteophytes, definite narrowing, and subchondral sclerosis. GAE tends to work best for mild to moderate arthritis (KL grades 2 and 3), though some patients with more advanced disease may also benefit.
What is the angiogram during GAE?
During the GAE procedure, a catheter is advanced through a small puncture in the groin to reach the genicular arteries around the knee. Contrast dye is injected to create a real-time X-ray map of the knee’s blood supply. This angiogram reveals areas of abnormal neovascularity in inflamed synovial tissue, appearing as a characteristic “synovial blush” pattern on the monitor. The physician uses this live map to selectively deliver microspheres to the pathological vessels while preserving normal blood supply.
Should I bring my imaging to the consultation?
Yes. Bring any recent knee imaging (X-rays or MRI) on disc or through a patient portal, or provide the imaging facility’s name so the studies can be requested. If you have had imaging at different facilities over time, bring all of it, because comparing older and newer studies helps your physician track disease progression. If you do not have recent imaging, it can be ordered at the consultation. Standing (weight-bearing) views are essential for accurate grading.
Can I get GAE if my X-rays show severe arthritis?
GAE tends to work best for mild to moderate arthritis (KL grades 2 and 3), though some patients with more advanced disease may also benefit. Grade 4 (bone-on-bone) arthritis is typically best addressed with knee replacement. However, patients who are not candidates for surgery, or who wish to delay it, may still be considered for GAE on a case-by-case basis. Your physician will review your imaging, symptoms, and goals to determine whether GAE is a reasonable option for your specific situation.
Disclaimer: This article is for informational purposes only and does not constitute medical advice.
References:
- Kellgren JH, Lawrence JS. Radiological Assessment of Osteo-Arthrosis. Ann Rheum Dis. 1957;16(4):494-502.
- Taslakian B, et al. Prospective Genicular Artery Embolization Trial. J Vasc Interv Radiol (JVIR). 2025.
- Cusumano LR, et al. Genicular Artery Embolization 2-Year IDE Trial Results. J Vasc Interv Radiol (JVIR). 2024.
- Gornik HL, et al. 2024 ACC/AHA Guideline for the Management of Lower Extremity PAD. J Am Coll Cardiol. 2024;83(24):2497-2604.
- Luyten FP, et al. Definition and Classification of Early Osteoarthritis of the Knee. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):401-406.
